Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
What ‘Big Tech’ Will Add to the Conversation at HLTH
October 2, 2019
“Technology companies such as Google, Microsoft, Apple, Oracle and Twitter are making inroads in healthcare. But will their efforts gain traction and scale? At HLTH, representatives from some of these companies will take part in the healthcare transformation conversation across AI, voice, diabetes management and more.”
The article outlines the contributions of healthcare technology companies at the HLTH conference, spotlighting FDNA’s innovative role. FDNA is at the forefront with its advanced AI-powered facial recognition technology designed to diagnose rare genetic diseases. By integrating cutting-edge algorithms, FDNA enhances the accuracy and efficiency of medical diagnoses, showcasing the transformative potential of healthcare technology companies. The discussion highlights how big tech innovations, like FDNA, are pivotal in improving patient outcomes through precision medicine.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…